Related Experiment Video
Updated: Jan 23, 2026
Ultrasonography of the Adult Male Urinary Tract for Urinary Functional Testing
Published on: August 14, 2019
Early Onset of Intradetrusor OnabotulinumtoxinA for Urgency Urinary Incontinence
Sarah Ashmore1, Margaret G Mueller, Michelle Mucasey
1Section of Urogynecology and Reconstructive Pelvic Surgery, University of Chicago, Chicago, IL.
Importance:
The onset of symptom improvement following intravesical onabotulinum toxinA for urgency urinary incontinence is not well known.
Objective:
The objective of this study was to evaluate the early efficacy of intradetrusor onabotulinumtoxinA for the treatment of urgency urinary incontinence.
Study Design:
We performed a prospective observational study of women undergoing intradetrusor onabotulinumtoxinA for the treatment of urgency urinary incontinence. Adult women receiving an initial or subsequent injection of 100 units of intradetrusor onabotulinumtoxinA were included. Participants completed 3-day baseline voiding diaries, the Urinary Distress Inventory-6, and Incontinence Impact Questionnaire-7 before the procedure. Voiding diaries, Urinary Distress Inventory-6, and Incontinence Impact Questionnaire-7 were repeated daily for 14 days postprocedure. Statistical analysis of paired data (preprocedure and postprocedure) was performed using the Wilcoxon signed-rank test.
Results:
Thirty-one participants completed baseline and follow-up questionnaires. The median (range) baseline Urinary Distress Inventory-6 was 33 (8-71) and the Incontinence Impact Questionnaire-7 was 38 (0-100). The median baseline daily voids, urgency urinary incontinence episodes, urgency episodes, and nocturia episodes were 13 (8-20), 5 (2-15), 8 (3-17), and 4 (0-6), respectively. For all measures, day 1 outcomes were significantly improved from baseline. Day 1 median Urinary Distress Inventory-6 was 25 (0-67), Incontinence Impact Questionnaire-7 was 24 (0-81), daily voids were 10 (5-20), daily urgency urinary incontinence episodes were 2 (0-15), daily urgency episodes were 3 (0-20), and daily nocturia episodes were 2 (0-4). Significant improvement persisted over the 14-day follow-up.
Conclusions:
Women undergoing intradetrusor onabotulinumtoxinA for urgency urinary incontinence had significant subjective and objective improvement 1 day postprocedure.
Related Concept Videos
01:13Introduction to Urinary System
The kidneys are bean-shaped organs located in the retroperitoneal space, on either side of the vertebral column, between the T12 and L3 vertebrae. They are partially protected by the rib cage and surrounded by perirenal fat, which provides cushioning. They are responsible for urine formation and play critical roles in regulating blood pressure, electrolyte levels, and hormone production. The ureters...
01:23Urinary Bladder
In males, the bladder is situated in front of the rectum, while in females, it is positioned anterior to the vagina and uterus. The bladder floor contains an inverted triangular area called the trigone, defined by the two ureteric...
01:20Disorders of the Urinary System
Urinary tract infections (UTIs) are one of the most common urinary system disorders. They are caused by bacteria that enter the urethra and can spread to the bladder resulting in cystitis. Pyelonephritis is the result of a UTI that has ascended to the level of the...
01:28Urinary Tract Calculi I: Introduction
01:26Urinary Tract Infection I: Introduction
01:25Urinary Tract Infection II: Pathophysiology